Pioglitazone Hydrochloride
13 NDCs across 3 manufacturers|13 Generic,0 Brand
Pioglitazone Hydrochloride is used to treat type 2 diabetes mellitus, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Jul 15, 1999, and the first generic was approved Aug 17, 2012. FDA's Orange Book lists 36 AB-rated (therapeutically equivalent) products for this ingredient.
Pioglitazone Hydrochloride is available as 13 NDCs from 3 manufacturers (13 generic, 0 brand), with NADAC prices from $0.06 to $0.11 per EA — a 72% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
13
13G / 0B
Manufacturers
3
competing in market
Price Spread
$0.06 – $0.11
per EA
7d Activity
avg -0.7% WoW · of 13 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
3 manufacturers producing PIOGLITAZONE HYDROCHLORIDE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
PIOGLITAZONE HCL 45 MG TABLET | $0.1111 per EA | -1.38% |
PIOGLITAZONE HCL 45 MG TABLET | $0.1111 per EA | -1.38% |
PIOGLITAZONE HCL 45 MG TABLET | $0.1111 per EA | -1.38% |
PIOGLITAZONE HCL 45 MG TABLET | $0.1111 per EA | -1.38% |
PIOGLITAZONE HCL 30 MG TABLET | $0.0903 per EA | +1.69% |
PIOGLITAZONE HCL 30 MG TABLET | $0.0903 per EA | +1.69% |
PIOGLITAZONE HCL 30 MG TABLET | $0.0903 per EA | +1.69% |
PIOGLITAZONE HCL 30 MG TABLET | $0.0903 per EA | +1.69% |
PIOGLITAZONE HCL 15 MG TABLET | $0.0647 per EA | -2.18% |
PIOGLITAZONE HCL 15 MG TABLET | $0.0647 per EA | -2.18% |
PIOGLITAZONE HCL 15 MG TABLET | $0.0647 per EA | -2.18% |
PIOGLITAZONE HCL 15 MG TABLET | $0.0647 per EA | -2.18% |
PIOGLITAZONE HCL 15 MG TABLET | $0.0647 per EA | -2.18% |
Frequently Asked Questions
What is Pioglitazone Hydrochloride used to treat?
Pioglitazone Hydrochloride is used to treat type 2 diabetes mellitus, per the National Library of Medicine's MED-RT classification.
When did Pioglitazone Hydrochloride become available as a generic?
FDA approved the first generic Pioglitazone Hydrochloride (ANDA) on Aug 17, 2012. The Orange Book currently lists 36 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How many Pioglitazone Hydrochloride products are on the market?
The Pioglitazone Hydrochloride drug market contains 13 NDCs from 3 manufacturers — 13 generic and 0 brand products.
What is the price range for Pioglitazone Hydrochloride?
NADAC reference prices for Pioglitazone Hydrochloride range from $0.0647 to $0.1111 per EA — a 72% difference between cheapest and most expensive.
Which manufacturers make Pioglitazone Hydrochloride?
3 manufacturers list Pioglitazone Hydrochloride in NADAC. Ranked by number of NDCs, the largest are Aurobindo Pharma Limited (7), Chartwell RX LLC (3), Quallent Pharmaceuticals Health LLC (3).
How has the price of Pioglitazone Hydrochloride changed recently?
Over the past 7 days, 12 Pioglitazone Hydrochloride NDCs rose and 27 fell, with a market-wide average change of -0.7%.